Profile
ABEO NVO VRTX REGN SGEN ARGX
Company Name Abeona Therapeutics Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $259.96M $473.53B $116.14B $79.76B $43.15B $36.58B
Employees 0.08K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Vishwas Seshadri M.B.A., Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABEO NVO VRTX REGN SGEN ARGX
Quant Rating Score 1 3 3 4 3 1
Quant Rating Strong Sell Neutral Neutral Buy Neutral Strong Sell
Trading
ABEO NVO VRTX REGN SGEN ARGX
Last Close $5.98 $105.06 $450.97 $738 $228.74 $605.92
High 52 $8.68 $146.91 $516.74 $1201.76 $228.74 $605.92
Low 52 $3.17 $101.74 $392.81 $738 $228.74 $356.01
Price vs. 52 Week High -31.11 % -28.49 % -12.73 % -38.59 % 0 % 0 %
Price vs. 52 Week Low 88.64 % 3.26 % 14.81 % 0 % 0 % 70.2 %
Total Return
ABEO NVO VRTX REGN SGEN ARGX
1 Month Return -4.32 % -9.23 % -4.06 % -21.61 % 0 % 8.6 %
3 Month Return 8.43 % -23.3 % -6.29 % -38.45 % 0 % 17.27 %
6 Month Return 43.41 % -22.5 % 0.04 % -24.74 % 0 % 67.84 %
9 Month Return -14.33 % -14.9 % 4.85 % -24.79 % 0 % 47.96 %
YTD Return 19.36 % 1.56 % 10.83 % -15.97 % 0 % 59.27 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.32 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -25.94 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ABEO NVO VRTX REGN SGEN ARGX
Asset Growth -0.33 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -68.67 % 32.32 % 9.25 % 6.49 % 22.93 % 190.7 %
Revenue Growth 147.52 % 31.26 % 10.17 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year -93.93 % 90.51 % 59.87 % 55.67 % 91.84 % 2074.24 %
Revenue 5 Year -89.62 % 124.2 % 218.58 % 110.3 % 215.48 % 3040.37 %
Revenue 10 Year -99.84 % 66.11 % 608.27 % 549.62 % 494.04 % 9013.37 %
EBIT Growth -6.5 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Net Income Growth -70.35 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 89.37 % 106.79 % 34.59 % 13.48 % -764.83 % 63.97 %
Net Income 5 Yeari Growth Per Share 91.5 % 133.86 % 70.33 % 74.02 % -276.93 % -143.56 %
Net Income 10 Yeari Growth Per Share -101.15 % 98.61 % 809.6 % 871.12 % -624.16 % -857.4 %
Operating Income Growth -6.5 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 14.89 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 81.68 % 118.29 % 9.63 % 76.95 % -148.34 % 21.62 %
Operating 5 Year CFG 91.59 % 163.51 % 174.78 % 125.17 % -195.86 % -329.48 %
Operating 10 Year CFG -3595.52 % 150.92 % 6084.35 % 713.56 % -2622.09 % -1280.79 %
EPS Growth 37.53 % 52.28 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 37.53 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -79.63 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -97.49 % 75.22 % 104.06 % 137.56 % 33.92 % 93.95 %
Share Holder 5 Year Equity Growth Per Share -99.02 % 121.9 % 291.14 % 219.1 % 220.81 % 318.67 %
Share Holder 10 Year Equity Growth Per Share 100.09 % 49.62 % 1030.79 % 1286.9 % 691.19 % 3655.65 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -29.2 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 14.38 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ABEO NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM -10.2 % 84.66 % 86.1 % 83.54 % 72.37 % 86.82 %
Return on Assets TTM -58.9 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -227.38 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -59.46 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 116.93 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -2151.13 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -247.07 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM 1.75 3.4 6.06 2.27 1.98 3.45
Payables Turnover TTM 1.12 1.72 3.73 4.58 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.76 0.65 0.91
Fixed Asset Turnover TTM 35.99 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 2.34 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -1.01 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -1.05 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 228.16 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -1724.19 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.85 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -247.07 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -5.14 50.51 -99.79 23.61 -141.85 -173.18
Price To Operating Cash Flows Ratio TTM -5.91 28.29 -138.08 18.78 -203.89 -250.16
Price Cash Flow Ratio TTM -5.91 28.29 -138.08 18.78 -203.89 -250.16
Income Statement (TTM)
ABEO NVO VRTX REGN SGEN ARGX
Revenue $0B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $0B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio 69.57% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.05B $114.63B $4.61B $4.65B $-0.62B $-0.22B
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -2.53 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ABEO NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.05B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.01B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.04B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.01B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.06B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ABEO NVO VRTX REGN SGEN ARGX
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.04B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.3
ABCL AbCellera Biologics Inc. 2.76
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.37
ABSI Absci Corporation 2.56
ABUS Arbutus Biopharma Corporation 3.51
ABVC ABVC BioPharma, Inc. 0.5488
ABVX Abivax SA American Depositary Shares 8.78
ACAD ACADIA Pharmaceuticals Inc. 16.37
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 0.9
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.06
ACHV Achieve Life Sciences, Inc. 4.29
ACIU AC Immune SA 3.38
ACLX Arcellx, Inc. 90.44
ACRV Acrivon Therapeutics, Inc. Common Stock 6.55
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 1.35
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 296.51
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00036 131.65
VXF Vanguard Extended Market Index Fund 0 203.42
IWC iShares Micro-Cap ETF 0.01821 135.74
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 102.82
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 102.8
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.75
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.74
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.74
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
DFAT Dimensional U.S. Targeted Value ETF 0 60.18
DFAS Dimensional U.S. Small Cap ETF 0.00020616 69.99
DFAC Dimensional U.S. Core Equity 2 ETF 0 36.06
VTSAX Vanguard Total Stock Market Index Fund 0 144.38
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 154.29
VITSX Vanguard Total Stock Market Index Fund 0 144.4
IBRN iShares Neuroscience and Healthcare ETF 0.19047 26.5401
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000165995 102.35
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 154.3
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 2.27736 23.615
VEMPX Vanguard Extended Market Index InstlPlus 0 380.77
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 270.87
Unlock